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Abstract
Introduction: Enterobacter cloacae infections are common among burn victims, immunocompromised patients, and 
patients with malignancy. Most commonly these infections are manifested as nosocomial urinary tract or pulmonary 
infections. Nosocomial outbreaks have also been associated with colonization of certain surgical equipment and 
operative cleaning solutions. Infections of an aortobifemoral prosthesis, an aortic graft, and arteriovenous fistulae are 
noted in the literature. To our knowledge, this is the first isolated account of an E. cloacae infection of a femoral-
popliteal expanded polytetrafluoroethylene bypass graft.
Case presentation: A 68-year-old Caucasian man presented with fever and rest pain in the right lower extremity five 
months after the placement of a vascular expanded polytetrafluoroethylene graft for femoral-popliteal bypass. 
Computed tomography angiography demonstrated peri-graft fluid that was aspirated percutaneously with image 
guidance and cultured to reveal E. cloacae. The graft was revised and then removed. The patient completed a six-week 
course of ceftazidime and is currently without signs of infection. There were no other reports of E. cloacae graft 
infections in any patients receiving treatment in the same surgical suite within a month of this report.
Conclusion: Isolated cases of E. cloacae infection of surgical bypass grafts are rare (unique in this setting). Clinicians 
should have a high index of suspicion for device contamination in such cases and should consider testing for possible 
microbial reservoirs. Graft removal is required due to the formation of biofilm and the recent emergence of 
Enterobacteriaceae producing extended-spectrum beta-lactamase in community acquired infections.
Introduction
Enterobacter cloacae infections are seen commonly in
burn victims, immunocompromised patients, and
patients with malignancy [1]. The urinary and pulmonary
systems are the organ systems most commonly colonized
in these patients. E. cloacae bacteremia can also occur
depending on the extent of immunocompromise.
Outbreaks of coloacae infections are recorded in a
number of hospital settings. Sporadic cases of E. cloacae
infections have been linked to contaminated admixed
intravenous fluids, total parenteral nutrition solutions,
enteral feedings, infant formula, cardioplegic solution,
and blood products [2-4]. Another potential reservoir for
nosocomial bacteremia is the heparin flush solution used
to irrigate certain intravascular devices continually. This
fluid had been implicated as a reservoir for outbreaks of
device-associated bacteremia in several instances [5].
Less commonly, outbreaks are linked to the coloniza-
tion of devices such as long-term tunneled hemodialysis
catheters. Buxton and colleagues reported an epidemic of
E. cloacae infections that was associated with disposable
transducer domes. During their initial setup the cham-
bers and domes were contaminated by the hands of hos-
pital personal who had handled contaminated transducer
heads [6]. West and colleagues also reported E. cloacae
sepsis resulting from transducer dome cracks. In this
study, disposable transducer domes were being re-steril-
ized with resultant cracks in the dome membrane holding
bacteria. Case series also document the colonization of
entire operative suites that require extensive decontami-
nation [4].
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Case presentation
A 68-year-old male presents to a rural clinic with a two-
week history of claudication and a one-day history of rest
pain and fever. His past medical history was relevant for
lower extremity arterial insufficiency and claudication in
his right leg for which he underwent a right femoral-
popliteal above the knee bypass using a 6mm expanded
polytetrafluoroethylene (ePTFE) graft in May 2007. The
graft was revised a month later in July 2007 when surveil-
lance ultrasound revealed an occlusion. Intra-operative
findings at that presentation included extensive calcific
atherosclerotic disease and aggressive intimal hyperplasia
in the popliteal artery. A small seroma around the distal
anastomosis was discovered and evacuated at that time.
There was no evidence of graft infection after thrombec-
tomy and revision. Our patient was started on coumadin
to maintain graft patency. His initial recovery was unre-
markable.
Four months later, our patient began to experience
claudication for two weeks and then developed rest pain
and fever. He did not display any tissue loss or sensory
changes. On physical exam, our patient's distal incision
was warm and slightly indurated. His temperature was
38.5°C. Pedal pulses were 2+ in the left extremity and
could not be palpated on the right.
Computed tomography angiography (CTA) of our
patient (Figure 1) revealed a peri-graft fluid collection in
the popliteal fossa of the right lower extremity and an
occluded femoral-popliteal graft. Our patient's white
blood cell count was 9000 cells with a 73% neutrophilia
and his sedimentation rate was 64 Westergren units
(mm/h). A CT-guided aspiration of the peri-graft fluid
(Figure 2) was cultured and revealed E. cloacae with sen-
sitivity to extended-spectrum cephalosporins, including
cefepime, cefpirome, and cefclidine. At that time, our
patient was started on a third generation cephalosporin,
1g intravenous ceftazidime every eight hours.
Six hours later, the patient underwent removal of the
graft. Endarterectomy with saphenous vein patch angio-
plasty was performed on the common femoral artery for
severe atherosclerotic stenosis. Collaterals from the deep
femoral artery were relied upon to perfuse the limb. Our
patient completed a six-week course of ceftazidime, cur-
rently uses the limb without discomfort, and is without
signs of infection.
Discussion
Synthetic peripheral bypass vascular grafts carry a high
morbidity [7]. The risk of complications is as high as 50%
in some studies. These risks include hemorrhage, limb
ischemia, amputation, revision, or infection [7,8]. Rates
for peripheral lower extremity prosthetic graft infection
are as high as 12% [7]. Risk factors for graft infection are
similar to those for wound infection and include obesity,
diabetes, cancer and other immunocompromised states,
as well as the use of immunosuppressive therapies. Our
patient had a history of lung cancer in remission, but was
without other risk factors.
The most common pathogen in graft infection is Staph-
ylococcus aureus, which is responsible for 35% of graft
infections. Gram-negative rods account for another 20%
Figure 1 CT angiogram of a small seroma in the right popliteal 
fossa taken prior to seroma biopsy and removal of the femoral-
popliteal ePTFE bypass graft. Arrows point to the location of the 
seroma.
Figure 2 CT image used in correlation with CT-guided drainage of 
the abscess created by graft infection. Cultures of aspirated material 
revealed colonies of E. cloacae. Arrows point to needle biopsy.Musil et al. Journal of Medical Case Reports 2010, 4:131
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of vascular graft infections. Other common organisms in
these infections include coagulase negative Staphylococ-
cus, Streptococcus milleri, Enterococcus faecium, Escheri-
chia coli, Bacteroides fragilis, Candida albicans and
Pseudomonus aeruginosa. Polymicrobial colonization is
commonly seen in immunocompromised patients. Grafts
that require groin incisions have the greatest risk for
infection, possibly due to contamination by bowel flora at
the time of implantation [9].
Nosocomial  E. cloacae infections are not entirely
uncommon. Their isolated occurrence among vascular
prosthetic grafts is rare, however. There are accounts of
E. cloacae infection of an aortobifemoral bypass prosthe-
sis and reports of E. cloacae infection in other types of
vascular grafts (including an aortic graft), but, to our
knowledge, this is the first account of an E. cloacae infec-
tion in a femoral-popliteal ePTFE bypass graft [10,11].
ePTFE is a woven form of PTFE, the same polymer used
in Teflon© (DuPont). Research demonstrates this material
is particularly prone to infection and biofilm formation
relative to autologous tissues [12].
From the clinical perspective, biofilms are a major
problem, since these structures display greatly increased
resistance to physical and chemical insults. Crucially, bio-
films are resistant to antibiotic treatment, making them
particularly difficult to eliminate from patients and con-
taminated surgical equipment [13]. Several case reports,
a s  w e l l  a s  l a r g e r  s t u d i e s  f r o m  C a n a d a ,  F r a n c e ,  I s r a e l ,
Spain, Italy and the UK indicate that infections caused by
extended spectrum Beta-lactamase (ESBL) Enterobacte-
r i a c e a e  i s  a n  e m e r g i n g  p r o b l e m  i n  o u t p a t i e n t  s e t t i n g s
[15]. Therefore, graft removal should always be consid-
ered.
Prosthetic vascular graft infections commonly occur
without specific symptoms [14]. Some authors suggest
surveillance in the absence of clinical symptoms with the
use of indium scan to identify infection. Clinical symp-
toms arose in this patient before surveillance could be
conducted. When signs and symptoms are present, diag-
noses of graft infection is still difficult and must often rely
on clinical basis alone as blood cultures are often negative
[16]. Most authors suggest the use of CTA as the most
appropriate study to identify infection when clinical sus-
picion is high [17]. Peri-graft fluid, ectopic air, abnormal
tissue planes or soft tissue swelling, and pseudoaneurysm
formation are all signs of graft infection on CT. Non-spe-
cific findings include fever, leukocytosis with left shift,
and elevated inflammation markers (erythrocyte sedi-
mentation rate, ESR; C-reactive protein, CRP). Absence
of other signs of graft infection should prompt a thorough
workup for other causes. CTA was used to identify the
nidus of infection in our patient.
Management requires resection of the infected graft,
arterial repair or bypass with autologous tissue, and long-
term antibiotics [18]. Placement of a new prosthetic graft
should be avoided in the presence of acute infection.
Adjuvant techniques of endarterectomy or percutaneous
revascularization may be helpful. The importance of
standard hospital and operating room hygiene measures
(disinfection of hands) must not be underestimated.
These measures are paramount to the control and pre-
vention of infection. When an isolated surgical case of E.
cloacae occurs, clinicians should have a high index of sus-
picion for device contamination, consider testing for pos-
sible microbial reservoirs, and also consider documenting
the case in the literature [14].
Conclusions
Currently, our patient experiences mild claudication, but
no rest pain. He has no evidence of infection following
the removal of his ePTFE graft, endarterectomy of the
common femoral artery, saphenous vein patch, and intra-
venous ceftazidime. Additionally, there are no records of
E. cloacae infection of any other patient at this hospital
within a month of original graft placement. This makes
widespread contamination of surgical equipment
unlikely.
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